Glasgow Launches Singapore MedTech Fund for Scottish Firms
The University of Glasgow has launched a fund to help Scottish MedTech companies test technologies and build partnerships in Singapore's healthcare sector.
Updated on Nov. 5, 2026 in Healthcare
Live Poll
Should Scottish universities use public funds to help local companies expand overseas?
The University of Glasgow has launched the MedTech Innovation Singapore Fund to support Scottish MedTech firms seeking to validate technologies and build commercial partnerships in Singapore's healthcare ecosystem. The pilot is led by the university's Innovation and Enterprise Programmes team and University of Glasgow Singapore, with support from Scottish Development International and other partners.
Why it matters
The fund aims to connect Scottish healthcare innovation with international partners in a growing Asian market. It builds on the university's existing spin-out track record and its presence in Singapore, established in 2011 as its first subsidiary outside Scotland.
Since 2010, University of Glasgow spin-out companies have attracted more than £150 million in investment and generated over £500 million in enterprise value. The fund's financial size and participant count have not been disclosed.
The players
University of Glasgow
A major public research university in Scotland whose spin-out companies and MedTech programmes are central to the fund. It established University of Glasgow Singapore in 2011 as its first subsidiary outside Scotland.
Scottish Development International
The international trade and investment arm of Scotland's economic development agency, which supports the pilot initiative. It helps Scottish businesses expand into overseas markets.
The details
The MedTech Innovation Singapore Fund supports innovators in testing and validating technologies and in building commercial partnerships within Singapore's healthcare ecosystem. The university is also supporting a trade mission to Singapore in February 2027 to connect Scottish entrepreneurs with healthcare providers, investors and potential partners.
Timeline
September 2026: The university welcomed the first students to its 12-month MedTech Innovation MSc.
February 2027: A trade mission to Singapore for Scottish entrepreneurs is planned.
Market Landscape
The fund extends the University of Glasgow's Singapore presence, which dates to its 2011 establishment as its first subsidiary outside Scotland, into a dedicated MedTech pathway. It positions Scottish healthcare innovators to compete for partnerships in Singapore's healthcare ecosystem.
For Scottish MedTech entrepreneurs, the fund offers a structured route to test technologies and find commercial partners in Singapore. Healthcare providers and investors in Singapore may gain access to Scottish innovations through these partnerships.
The takeaway
International expansion for healthcare innovation increasingly depends on early validation and local partnerships, and university-backed funds can lower the barrier for smaller firms. Companies weighing overseas markets can benefit from programmes that combine testing support with trade missions.
What happens next
A trade mission to Singapore for Scottish entrepreneurs is scheduled for February 2027.
Further reading
Explore more Healthcare coverage for context on how medical technology companies are expanding into international markets.
Live Poll
Should Scottish universities use public funds to help local companies expand overseas?
